Spinal Additives for C-Sections: Enhanced Recovery or Delayed Mobility
Notes de l’épisode
In this episode, we unpack a massive 2026 systematic review and network meta-analysis covering nearly 15,000 patients and 166 clinical trials on intrathecal adjuvants used during cesarean delivery. From morphine and dexmedetomidine to fentanyl combinations and off-label spinal agents, we explore which medications truly extend pain relief, reduce opioid use, and improve recovery, without increasing serious side effects. What does the evidence actually support, and where does uncertainty still remain?
Read more about this study HERE.
======================================
Where else to find us:
Web - https://www.nysora.com/
Instagram - instagram.com/nysora.inc/
LinkedIn - linkedin.com/company/nysora-inc/
Facebook - facebook.com/nysora
Twitter - x.com/nysora
TikTok - tiktok.com/@nysora_inc
---------------------------------------------------------
#nysora #regionalanesthesia #anesthesia
Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.